← Back to articles
Metabolic Health

FDA approved, compounded, and unapproved are not synonyms

A plain-language map of product categories that are often blurred in peptide discussions.

Share

Educational information only — not medical advice. This material cannot diagnose a condition, recommend treatment, or replace care from a qualified clinician who knows your history. The Peptide Center uses an evidence-first editorial process that prioritizes primary regulatory sources, trial registries, and peer-reviewed research; uncertainty and evidence limits should be part of every health claim.

FDA approval applies to a specific complete product for defined uses after agency review. A compounded drug may be prepared for an individual patient under applicable law, but it is not FDA approved. An unapproved product has not received FDA approval. Evidence and labeling for an approved product should not be attributed to a compounded or unapproved version. Read the FDA safety information on unapproved GLP-1 products.

References

  1. FDA's concerns with unapproved GLP-1 drugs used for weight loss
  2. Compounding and the FDA: Questions and Answers

Related resources

Continue with curated, same-topic resources from the published library. These links are educational references, not treatment recommendations.